{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:50:20Z","timestamp":1785880220329,"version":"3.56.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012112","name":"Swedish Orphan Biovitrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jtha.2026.04.005","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T08:23:47Z","timestamp":1775809427000},"page":"2341-2354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnosis and management of hemophilia A and B"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5208-3387","authenticated-orcid":false,"given":"Ming Y.","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3192-3926","authenticated-orcid":false,"given":"Jes\u00fas","family":"Ardila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4973-1317","authenticated-orcid":false,"given":"Giancarlo","family":"Castaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4888-1463","authenticated-orcid":false,"given":"Yesim","family":"Dargaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0904-4360","authenticated-orcid":false,"given":"Karin","family":"Fijnvandraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6465-7624","authenticated-orcid":false,"given":"Roberta","family":"Gualtierotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5429-8437","authenticated-orcid":false,"given":"Cedric","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0402-0802","authenticated-orcid":false,"given":"Susan","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.04.005_bib1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/jth.12854","article-title":"Phenotype-genotype correlations in hemophilia A carriers are consistent with the binary role of the phase between F8 and X-chromosome inactivation","volume":"13","author":"Radic","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.7326\/M19-1208","article-title":"Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries","volume":"171","author":"Iorio","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2026.04.005_bib4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jtha.2024.12.004","article-title":"The history of women and hemophilia: a narrative review of evolving beliefs and testing practices","volume":"23","author":"Chaigneau","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"Suppl 6","key":"10.1016\/j.jtha.2026.04.005_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH guidelines for the Management of Hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib9","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"Blanchette","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib10","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1182\/blood.2025029829","article-title":"F8 gene variants influence the response to desmopressin in hemophilia A carriers","volume":"146","author":"Guillet","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.04.005_bib11","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/jth.15805","article-title":"Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United States","volume":"20","author":"Johnsen","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e2707","article-title":"Diagnosis and management of haemophilia","volume":"344","author":"Fijnvandraat","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2026.04.005_bib15","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1182\/blood.2021011849","article-title":"Incidence and mortality rates of intracranial hemorrhage in hemophilia: a systematic review and meta-analysis","volume":"138","author":"Zwagemaker","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.04.005_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajh.1146","article-title":"Changes in the occurrence of and risk factors for hemophilia-associated intracranial hemorrhage","volume":"68","author":"Nuss","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.04.005_bib17","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.jtha.2024.05.030","article-title":"Bleeding phenotype according to factor level in 825 children with nonsevere hemophilia: data from the PedNet cohort","volume":"22","author":"de Kovel","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib18","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/jth.15444","article-title":"Hemophilic arthropathy: current knowledge and future perspectives","volume":"19","author":"Gualtierotti","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib19","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1111\/hae.12316","article-title":"Musculoskeletal evaluation in severe haemophilia A patients from Latin America","volume":"20","author":"Ozelo","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib20","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/ajh.24133","article-title":"Vascular remodeling underlies rebleeding in hemophilic arthropathy","volume":"90","author":"Bhat","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.04.005_bib21","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ijom.2017.04.016","article-title":"Ten-year study of postoperative complications following dental extractions in patients with inherited bleeding disorders","volume":"46","author":"Hsieh","year":"2017","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.jtha.2026.04.005_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619888023","article-title":"Differences in major bleeding events between patients with severe hemophilia A and hemophilia B: a nationwide, population-based cohort study","volume":"25","author":"Shih","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood-2024-207022","article-title":"Postpartum hemorrhage in hemophilia A and B carriers after enhanced prophylactic clotting factor suppletion: the pregnancy and inherited bleeding disorders study (PRIDES)","volume":"144","author":"de Vaan","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.04.005_bib24","article-title":"Diagnosis and management of abnormal uterine bleeding in adolescence: an expert Consensus Statement of SIGO (Italian Society of Gynecology and Obstetrics) and SISET (Italian Society for the Study of Hemostasis and Thrombosis)","volume":"3","author":"Santi","year":"2024","journal-title":"Bleeding Thromb Vasc Biol Biology"},{"key":"10.1016\/j.jtha.2026.04.005_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-09-3879","article-title":"Bleeding in carriers of hemophilia","volume":"108","author":"Plug","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.04.005_bib26","series-title":"Diagnosis of hemophilia and other bleeding disorders: a laboratory manual","author":"Kitchen","year":"2010"},{"key":"10.1016\/j.jtha.2026.04.005_bib27","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1111\/jth.14315","article-title":"The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTH","volume":"16","author":"Makris","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jtha.2024.10.030","article-title":"Comparing one stage, chromogenic assay results and discrepancies with bleeding phenotype and genetic variants in females with hemophilia A","volume":"23","author":"Srivaths","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib29","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1182\/blood.2024026804","article-title":"DDAVP response and its determinants in bleeding disorders: a systematic review and meta-analysis","volume":"145","author":"Laan","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.04.005_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3324\/haematol.2018.187567","article-title":"Use of desmopressin in the treatment of hemophilia A: towards a golden jubilee","volume":"103","author":"Mannucci","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.04.005_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"357","author":"Manco-Johnson","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.04.005_bib33","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1538-7836.2011.04214.x","article-title":"A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)","volume":"9","author":"Gringeri","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib34","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/jth.13811","article-title":"Effect of late prophylaxis in hemophilia on joint status: a randomized trial","volume":"15","author":"Manco-Johnson","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib35","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/j.jtha.2024.05.026","article-title":"International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the grading of recommendations assessment, development, and evaluation methodology","volume":"22","author":"Rezende","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/2040620718796429","article-title":"Practical aspects of extended half-life products for the treatment of haemophilia","volume":"9","author":"Lambert","year":"2018","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.jtha.2026.04.005_bib37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJMoa2209226","article-title":"Efanesoctocog alfa prophylaxis for patients with severe hemophilia A","volume":"388","author":"von Drygalski","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.04.005_bib38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa1803550","article-title":"Emicizumab prophylaxis in patients who have hemophilia A without inhibitors","volume":"379","author":"Mahlangu","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.04.005_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.102693","article-title":"A literature review of major surgery experience with emicizumab in people with hemophilia A without factor VIII inhibitors","volume":"9","author":"Castaman","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib40","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jtha.2023.09.034","article-title":"A bispecific antibody NXT007 exerts a hemostatic activity in hemophilia A monkeys enough to keep a nonhemophilic state","volume":"22","author":"Teranishi-Ikawa","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-0044-1796651","article-title":"Non-factor Therapies for Hemophilia: achievements and perspectives","volume":"51","author":"Jimenez-Yuste","year":"2025","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl 3","key":"10.1016\/j.jtha.2026.04.005_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/hae.14976","article-title":"Benefits and risks of non-factor therapies: Redefining haemophilia treatment goals in the era of new technologies","volume":"30","author":"Mancuso","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/hae.15125","article-title":"UKHCDO gene therapy taskforce: guidance for implementation of haemophilia gene therapy into routine clinical practice for adults","volume":"31","author":"Chowdary","year":"2025","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib45","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jtha.2025.12.011","article-title":"Overview of gene therapy for hemophilia: questions and answers to navigate the innovation","volume":"24","author":"Hoffmann","year":"2026","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1182\/hematology.2022000388","article-title":"Gene therapy for hemophilia","volume":"2022","author":"Nathwani","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2026.04.005_bib47","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1160\/TH12-02-0108","article-title":"Survey of laboratory tests used in the diagnosis and evaluation of haemophilia A","volume":"109","author":"Gomez","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib48","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.25153","article-title":"Shifting landscape of hemophilia therapy: implications for current clinical laboratory coagulation assays","volume":"93","author":"Al-Samkari","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.04.005_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/hae.13903","article-title":"Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors\u2019 Organisation guideline","volume":"26","author":"Jenkins","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib50","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1055\/s-0039-1688687","article-title":"Effects and interferences of emicizumab, a humanised bispecific antibody mimicking activated factor VIII cofactor function, on coagulation assays","volume":"119","author":"Adamkewicz","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib51","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/jth.12990","article-title":"Inhibitor development and mortality in non-severe hemophilia A","volume":"13","author":"Eckhardt","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib52","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ajh.23957","article-title":"Impact of inhibitors on hemophilia A mortality in the United States","volume":"90","author":"Walsh","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.04.005_bib53","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1182\/bloodadvances.2020002626","article-title":"Inhibitors and mortality in persons with nonsevere hemophilia A in the United States","volume":"4","author":"Lim","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.04.005_bib54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3324\/haematol.2019.239160","article-title":"Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study","volume":"106","author":"Male","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.04.005_bib55","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/hae.70039","article-title":"Trends in treatment of severe haemophilia and impact on inhibitor assessment by the EUHASS Registry","volume":"31","author":"Fischer","year":"2025","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102265","article-title":"Inhibitor development according to concentrate in severe hemophilia: reporting on 1392 previously untreated patients from Europe and Canada","volume":"7","author":"Fischer","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib57","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood-2013-02-483263","article-title":"Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A","volume":"122","author":"Eckhardt","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.04.005_bib58","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-0037-1612626","article-title":"Inhibitors in hemophilia: treatment challenges and novel options","volume":"44","author":"Barg","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib59","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood.2019001869","article-title":"A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors","volume":"134","author":"Young","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.04.005_bib60","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1182\/blood-2010-06-291906","article-title":"Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgery","volume":"116","author":"Dargaud","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.04.005_bib61","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1055\/s-0029-1245107","article-title":"Improvements in factor VIII inhibitor detection: from Bethesda to Nijmegen","volume":"35","author":"Verbruggen","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib62","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1703068","article-title":"Emicizumab prophylaxis in hemophilia A with Inhibitors","volume":"377","author":"Oldenburg","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.04.005_bib63","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1021\/acsptsci.4c00560","article-title":"Advances in development of drug treatment for hemophilia with inhibitors","volume":"7","author":"Wichaiyo","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.jtha.2026.04.005_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.102926","article-title":"Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice","volume":"9","author":"Sidonio","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.jtha.2026.04.005_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2516.2007.01497.x","article-title":"International workshop on immune tolerance induction: consensus recommendations","volume":"13","author":"DiMichele","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib66","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/hae.14470","article-title":"Immune tolerance induction in the era of emicizumab - still the first choice for patients with haemophilia A and inhibitors?","volume":"28","author":"Holstein","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib67","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1182\/blood-2011-08-369132","article-title":"The principal results of the international immune tolerance study: a randomized dose comparison","volume":"119","author":"Hay","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.04.005_bib68","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000495454","article-title":"Inhibitors: a need for eradication?","volume":"141","author":"Santagostino","year":"2019","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jtha.2026.04.005_bib69","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0037-1612943","article-title":"The North American Immune Tolerance Registry: practices, outcomes, outcome predictors","volume":"87","author":"DiMichele","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib70","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2516.2007.01437.x","article-title":"F8 gene mutation profile and ITT response in a cohort of Italian haemophilia A patients with inhibitors","volume":"13","author":"Salviato","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib71","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/hae.13762","article-title":"The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab","volume":"25","author":"Carcao","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib72","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/hae.14861","article-title":"Subclinical synovial proliferation in patients with severe haemophilia A: the value of ultrasound screening and biochemical markers","volume":"29","author":"van Bergen","year":"2023","journal-title":"Hemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib73","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.16039.1","article-title":"Merging into the mainstream: the evolution of the role of point-of-care musculoskeletal ultrasound in hemophilia","volume":"8","author":"Bakeer","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.jtha.2026.04.005_bib74","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1186\/s12891-022-06042-w","article-title":"The role of point-of-care musculoskeletal ultrasound for routine joint evaluation and management in the hemophilia clinic - a real world experience","volume":"23","author":"Gallastegui","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jtha.2026.04.005_bib75","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1016\/j.jtha.2024.08.018","article-title":"The management of liver disease in people with congenital bleeding disorders: guidance from European Association for Haemophilia and Allied Disorders, European Haemophilia Consortium, ISTH, and World Federation of Hemophilia","volume":"22","author":"La Mura","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib76","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1160\/TH12-05-0313","article-title":"Increased prevalence of hypertension in haemophilia patients","volume":"108","author":"Fransen van de Putte","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.04.005_bib77","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/bjh.18085","article-title":"Cardiovascular disease in hereditary haemophilia: the challenges of longevity","volume":"197","author":"Shapiro","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.04.005_bib78","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/obr.12746","article-title":"Obesity in the global haemophilia population: prevalence, implications and expert opinions for weight management","volume":"19","author":"Wilding","year":"2018","journal-title":"Obes Rev"},{"key":"10.1016\/j.jtha.2026.04.005_bib79","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.04.005_bib80","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2015-12-635094","article-title":"How I treat patients with inherited bleeding disorders who need anticoagulant therapy","volume":"128","author":"Martin","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.04.005_bib81","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1182\/blood-2016-07-727032","article-title":"New concepts for anticoagulant therapy in persons with hemophilia","volume":"128","author":"Schutgens","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.04.005_bib82","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000900","article-title":"Antithrombotic treatment in patients with hemophilia: an EHA-ISTH-EAHAD-ESO clinical practice guidance","volume":"7","author":"Schutgens","year":"2023","journal-title":"Hemasphere"},{"key":"10.1016\/j.jtha.2026.04.005_bib83","first-page":"736","volume":"405","author":"Chowdary","year":"2025","journal-title":"Haemophilia Lancet"},{"key":"10.1016\/j.jtha.2026.04.005_bib84","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/hae.14566","article-title":"European principles of care for physiotherapy provision for persons with inherited bleeding disorders: perspectives of physiotherapists and patients","volume":"28","author":"de Kleijn","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib85","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1111\/hae.14440","article-title":"Implications of haemophilia gene therapy for the changing role of the multidisciplinary team","volume":"28","author":"Miesbach","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib86","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/hae.14974","article-title":"The role of the specialist nurse in comprehensive care for bleeding disorders in Europe: an integrative review","volume":"30","author":"Mulders","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib87","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/hae.14002","article-title":"The UK haemophilia specialist nurse: competencies fit for practice in the 21st century","volume":"26","author":"Pollard","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib88","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/hae.70054","article-title":"European principles of nursing care for persons with inherited bleeding disorders","volume":"31","author":"Uitslager","year":"2025","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib89","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/hae.14379","article-title":"European principles of care for women and girls with inherited bleeding disorders","volume":"27","author":"van Galen","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.04.005_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.103203","article-title":"Building access to care for women and girls+ with bleeding disorders: the WGBD clinic of excellence model","volume":"9","author":"Lim","year":"2025","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626002217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626002217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:27:43Z","timestamp":1785878863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626002217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":82,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1538783626002217"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.04.005","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of hemophilia A and B","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}